NCT04576364View on ClinicalTrials.gov

12-hour Versus 24-hour Postpartum Magnesium Sulphate for Preeclamptic Patients

NACompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 20, 2022

Study Completion Date

November 30, 2022

Conditions
Maternal Care Patterns
Interventions
DRUG

Magnesium sulfate for 12 hour

drug used to prevent convulsions in patients having preeclampsia with severe features

DRUG

Magnesium sulfate for 24 hour

drug used to prevent convulsions in patients having preeclampsia with severe features

Trial Locations (2)

71511

Assuit University women Health hospital, Asyut

Mai mahoud, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04576364 - 12-hour Versus 24-hour Postpartum Magnesium Sulphate for Preeclamptic Patients | Biotech Hunter | Biotech Hunter